Scientists at Yale University have pioneered a groundbreaking mRNA vaccine platform that markedly boosts immune response, enhances vaccine efficacy, and broadens its utility in preventing and treating a myriad of diseases. This platform ingeniously directs proteins to the cell surface through the integration of a "cell GPS" module, thereby optimizing antigen exposure. The research breakthrough has been featured in Nature Biomedical Engineering.
